Modulight (MODU) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
24 Apr, 2026Executive summary
EBITDA rose 157% year-over-year to €330k (22.1% margin), despite a 7% revenue decline to €1,495k, driven by operational efficiency and a growing product development pipeline of 36 projects.
Customer activity and pipeline projects increased, with three major new customer accounts added and 44% of customers now large enterprises (>€1bn revenue).
The Pay-Per-Treatment (PPT) business model invoicing grew by over 100% year-over-year, with more than 80 sites now active and strong progress in site expansion.
The updated strategy focuses on scaling PPT, ramping up operations, leveraging synergies, and expanding into new high value-add applications.
Vertically integrated production and expanded US and Asian operations enhance competitiveness and supply chain security.
Financial highlights
Q1 2026 revenue was €1,495k, down from €1,606k year-over-year due to delivery delays and product mix shifts.
EBITDA improved to €330k (22.1% margin) from €-582k (-36.2% margin) year-over-year.
Operating profit (EBIT) was €-1,064k, a 33% improvement from €-1,585k.
Free cash flow from operations improved to €-661k from €-1,551k; net cash flow was €-474k versus €-2,900k.
Cash and cash equivalents at period end were €9,080k; net debt improved to €-6,590k.
Outlook and guidance
Management expects revenue and EBITDA growth for full-year 2026, with guidance to be updated as needed.
Main focus is on ramping up production, increasing PPT site numbers, and transitioning to the PPT business model, with ongoing quarterly fluctuations expected.
Latest events from Modulight
- Record revenue growth and strong EBITDA, driven by PPT expansion and project pipeline.MODU
Q4 202513 Apr 2026 - Q2 2024 revenue fell 13% YoY, but EBITDA loss narrowed and cash flow improved as the pipeline grew.MODU
Q2 202423 Jan 2026 - Q3 revenue up 58% YoY, EBITDA loss narrows, and PPT model and R&D pipeline expand.MODU
Q3 202419 Jan 2026 - Revenue up 52% and EBITDA up 56%, driven by US growth and pay-per-treatment expansion.MODU
Q1 202524 Dec 2025 - Q4 revenue up 40% YoY, cash flow and margins improved as PPT model reached 50 hospitals.MODU
Q4 202424 Dec 2025 - Q2 revenue doubled and EBITDA neared zero as the pipeline and global customer base expanded.MODU
Q2 202523 Nov 2025 - Revenue up 176% YoY, losses narrowing, and PPT business driving strong operational gains.MODU
Q3 202531 Oct 2025